FDA Adverse Event Malfunction Summary report: N

EXEL IV CATH 22GX1"

MDR report key: 25246222 · Received May 21, 2026

Report

Report Number
1035907-2026-00053
Event Type
Malfunction
Date Received
May 21, 2026
Report Date
May 21, 2026
Manufacturer
EXELINT INTERNATIONAL, CO.
Product Code
FOZ
UDI-DI
00020221267464
PMA / PMN Number
K895768
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
501

Narratives

Additional Manufacturer Narrative · 0

AN INVESTIGATION WAS CONDUCTED ON PRODUCT # 26746, LOT # 240902, WHICH INCLUDED THE FOLLOWING: INCOMING INSPECTION AN INCOMING INSPECTION HAS BEEN PERFORMED IN ACCORDANCE WITH SOP-11 INCOMING INSPECTION PROCEDURE ON PRODUCT # 26427, LOT #240902. THE BATCH MET THE ESTABLISHED CRITERIA FOR PRODUCT RELEASE, AND NO NONCONFORMITIES WERE IDENTIFIED. PRODUCTION PROCESS REVIEW THE BATCH RECORDS OF THE PRODUCTION PROCESS AND THE FINISHED PRODUCT INSPECTION REPORTS WERE REVIEWED. NO CHANGES TO RAW MATERIALS, PRODUCTION PROCESSES, OR INSPECTION METHODS WERE IDENTIFIED. ALL REVIEWED DOCUMENTATIONS COMPLIED WITH PRODUCT RELEASE STANDARDS REQUIREMENTS AND THE FINISHED PRODUCTS MET ALL SPECIFIED ACCEPTANCE CRITERIA. NO ABNORMALITIES OR NON-CONFORMITIES WERE FOUND. RETAINED SAMPLES INSPECTION FIFTY RETAINED SAMPLES OF INDWELLING CATHETERS FROM PRODUCT # 26746, LOT #240902 WERE SUBJECTED TO VISUAL INSPECTION. ALL SAMPLES WERE FOUND TO BE CLEAN AND FREE OF FOREIGN MATTER. ADDITIONALLY, FIVE SAMPLES FROM THE RETAINED SAMPLES UNDERWENT VISUAL INSPECTION OF THE NEEDLE TUBES. NO VISIBLE ACCUMULATION OF LUBRICANT OR LIQUID DROPLETS WAS OBSERVED. CAUSE ANALYSIS BASED ON THE CUSTOMER'S DESCRIPTION, IT IS LIKELY THAT THE "LIQUID/WATER" IS THE ACCUMULATION OF SILICON OIL LUBRICANT OVER TIME, WHICH MAY APPEAR AS LIQUID OR WATER-LIKE DROPLETS. SUCH ACCUMULATION IS DIFFICULT TO DETECT DURING THE PRODUCTION PROCESS BECAUSE THE MATERIAL MAY REQUIRE TIME BEFORE BECOMING VISIBLE. THE LUBRICANT USED IN THE PRODUCT IS DIMETHYL SILICON OIL, WHICH HAS BEEN PREVIOUSLY EVALUATED THROUGH BIOLOGICAL EVALUATION AND HAS BEEN DETERMINED TO BE SUITABLE FOR INTENDED CLINICAL USE. HOWEVER, THE CUSTOMER DID NOT RETURN THE SAMPLES FOR, CONFORMITY TESTING COULD NOT BE PERFORMED. BASED ON THE AVAILABLE DATA, THE EXACT ROOT CAUSE COULD NOT BE DETERMINED. POTENTIAL EXPLANATION COULD BE A LOCALIZED ACCUMULATION OF SILICON OIL; HOWEVER, THIS REMAINS UNCONFIRMED. THIS COMPLAINT WILL BE CLOSED IN OUR SYSTEM. NO SIMILAR COMPLAINTS WITHIN THE LOT. (B)(4).

Description of Event or Problem · 0

CUSTOMER REPORTED USING 22G CATHETERS AND WHEN THEY OPENED THE CAP FROM THE SEAL THERE WAS VISIBLE WATER/LIQUID. NO ADVERSE EVENT NOTED AS THE ISSUE WAS DISCOVERED BEFORE USED ON A PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
559216 EXEL IV CATH 22GX1" IV CATHETER FOZ EXELINT INTERNATIONAL, CO. 240902 00020221267464

Patients

Seq Age Sex Outcome Treatment
1